TP53 and ovarian cancer: Importantly, disruption of TP53, ERBB, and MAPK pathways has been implicated in ovarian tumorigenesis [57–60], focal adhesion is the most deregulated pathway in ovarian cancer [61], and B-cell infiltration of ovarian carcinoma effusions is associated with worse outcomes [62].